Financing and incentives for neglected disease Research and Development : Opportunities and challenges
This issue 3 of DNDi Outlook presents comments to the WHO Consultative Expert Working Group on the opportunities and challenges for financing and incentives for R&D on neglected diseases. It discusses the landscape for new R&D; the need to increase funding; and the need for an open model of sharing knowledge and data to create a more enabling research environment. It was concluded that the urgency of providing the necessary health tools to address the global neglected disease burden requires an expeditious and efficient response from all actors. At a time when many new actors, new policy proposals, and new funding initiatives have emerged in the field of health R&D, the WHO Global Strategy on Public Health, Innovation, and Intellectual Property could mark a turning point. Policymakers have the mandate to design a sustainable strategy and plan to empower existing initiatives and design better policies to boost innovation and ensure equitable access to the fruits of this innovation.
DNDi. Financing & incentives for neglected disease R&D: Opportunities and challenges. DNDi Outlook (2011) 3: 4 pp. [Comments to the WHO Consultative Expert Working Group (CEWG)on Research & Development: Financing and Coordination]